ELAN Elanco Animal Health Incorporated

26.29USD-1.54%Mkt Cap: 13.14B USDP/E: —

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vac…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap13.14B USD
Enterprise Value16.90B USD
Revenue (TTM)5.15B USD
Gross Profit2.59B USD
Net Income (TTM)-232.00M USD
Revenue/Share10.33 USD
Last Price26.29 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees9.4K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)20.34
PEG4.04
EV/EBITDA15.84
EV/Revenue3.28
P/S2.55
P/B1.98
EPS (TTM)-0.30 USD
EPS (Forward)1.29 USD
52W Range
19.4080% of range27.98
52W High27.98 USD
52W Low19.40 USD
Profitability
Gross Margin54.99%
Oper. Margin7.71%
EBITDA Margin20.73%
Profit Margin-4.92%
ROE-3.54%
ROA-1.74%
ROIC2.52%
ROCE2.14%
Growth
Revenue Growth11.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF560.00M USD
CapEx (TTM)276.00M USD
FCF Margin13.31%
FCF Yield5.21%
Net Debt3.55B USD
Net Debt/EBITDA3.33
Net Debt/FCF5.18
Balance Sheet
Debt/Equity0.61
Current Ratio2.08
Quick Ratio0.85
Book Value/Sh13.26 USD
Cash/Share0.93 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)31.15 USD
Upside (mean)+18.5%
Target Range25.00 USD – 35.00 USD
25.00+18.5% to mean35.00
# Analysts13
Ownership
Shares Out.499.83M
Float495.61M
Insiders1.21%
Institutions109.04%
Short Interest
Short Ratio6.9d
Short % Float10.47%
Short % Out.6.59%
Shares Short32.92M
Short (prev mo.)37.29M
Technical
SMA 5023.42 (+12.3%)
SMA 20023.87 (+10.2%)
Beta1.72
S&P 52W Chg12.08%
Avg Vol (30d)5.26M
Avg Vol (10d)6.32M
Technical Indicators
RSI (14)60.2
MACD0.9217
MACD Signal0.8344
MACD Hist.+0.0873
BB Upper28.29 USD
BB Middle24.95 USD
BB Lower21.62 USD
BB Width26.75%
ATR (14)0.9809 USD
Vol Ratio (20d)1.30x

About Elanco Animal Health (NYSE: ELAN)

›

Elanco Animal Health (NYSE: ELAN) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 9,400 employees.

The shares were at 26.29 USD on 19 November 2026, up 24.7% over 52 weeks. Its 52-week range is 19.40 USD to 27.98 USD: the price is 6.0% below the high and 35.5% above the low.

Its market capitalisation is 13.14B USD.

Elanco Animal Health reports return on equity of -3.5%, an operating margin of 7.7% and revenue up 11.3% year over year.

Its debt exceeds its cash by 3.55B USD, a debt-to-equity ratio of 0.61. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 13 analysts cover the stock, with an average rating of Buy; their mean price target of 31.15 USD is 18.5% above the current price. The next earnings report is expected on 23 February 2027.